Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Barnett Gregory

33 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 14 Mechanism of Action 11 Inflammation 11 Receptor Pharmacology 9 Animal Study 9 Safety 5 Biomarkers 5 PTSD 5 Neuroplasticity 4 Clinical Trial 4 Addiction 4 Toxicity 3

Journals

The American journal of psychiatry 5 Journal of psychopharmacology (Oxford, England) 2 Psychopharmacology 1 Science (New York, N.Y.) 1 Molecular psychiatry 1 Journal of Psychopharmacology 1 Journal of Analytical Toxicology 1 Journal of Affective Disorders 1

Publication history

Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.Psychopharmacology · 2026-09-15 Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.Science (New York, N.Y.) · 2026-09-03 Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28 Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorderJournal of Psychopharmacology · 2026-07-16 Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-06-04 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01 Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01 THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICEZenodo (CERN European Organization for Nuclear Research) · 2026-03-01 Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12 No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.Nature communications · 2026-01-22 Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01 Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models.bioRxiv: the preprint server for biology · 2025-07-07 There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.The American journal of psychiatry · 2025-06-01 ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01 Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-04-01 LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23 Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025-01-01 Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.Frontiers in neurology · 2025-01-01 Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03 Psilocybin and eugenol prevent DSS-induced neuroinflammation in miceBiocatalysis and Agricultural Biotechnology · 2024-01-25 Must Psilocybin Always "Assist Psychotherapy"?The American journal of psychiatry · 2024-01-01 Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.The American journal of psychiatry · 2024-01-01 Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.Life (Basel, Switzerland) · 2023-12-15 A history and future of psychedelics: The case of the Canadian military.Journal of military, veteran and family health · 2023-12-01 Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.Current issues in molecular biology · 2023-08-15 The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14 A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.The American journal of psychiatry · 2022-12-01 The Emerging Field of Psychedelic Psychotherapy.Current psychiatry reports · 2022-10-01 Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.Frontiers in pharmacology · 2022-01-01 Psychedelics as a treatment for disorders of consciousness.Neuroscience of consciousness · 2019-01-01 The relationships of classic psychedelic use with criminal behavior in the United States adult population.Journal of psychopharmacology (Oxford, England) · 2018-01-01 Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01 Analysis and Cultivation of Fruit Bodies and Mycelia of Psilocybe bohemicaBiochemie und Physiologie der Pflanzen · 1989-01-01

Author directory